We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+11.35%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$81.6B
AUM Growth
+$7.7B
Cap. Flow
+$798M
Cap. Flow %
0.98%
Top 10 Hldgs %
23.85%
Holding
3,095
New
53
Increased
1,513
Reduced
1,408
Closed
84

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$65.3M
2
AMZN icon
Amazon
AMZN
+$50M
3
TSLA icon
Tesla
TSLA
+$30.5M
4
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$26.6M
5
EPAM icon
EPAM Systems
EPAM
+$26.3M

Top Sells

Rank Stock Value
1
KSU
Kansas City Southern
KSU
+$39.1M
2
HRC
HILL-ROM HOLDINGS, INC.
HRC
+$31.2M
3
XEC
CIMAREX ENERGY CO
XEC
+$23.4M
4
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$21.9M
5
SBNY
Signature Bank
SBNY
+$17.7M

Sector Composition

Rank Sector Weight
1 Technology 25.54%
2 Financials 13.15%
3 Healthcare 12.95%
4 Consumer Discretionary 12.27%
5 Industrials 8.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
STR
2876
DELISTED
Sitio Royalties
STR
$163K ﹤0.01%
8,374
+409
+5% +$8.72K
APLT
2877
DELISTED
Applied Therapeutics
APLT
$162K ﹤0.01%
18,115
-321
-2% -$4.21K
IMUX icon
2878
Immunic
IMUX
$195M
$162K ﹤0.01%
1,694
+162
+11% +$14.6K
DLTH icon
2879
Duluth Holdings
DLTH
$159M
$161K ﹤0.01%
10,602
-220
-2% -$3.32K
CTXR icon
2880
Citius Pharmaceuticals
CTXR
$18.7M
$160K ﹤0.01%
4,159
-158
-4% -$7.17K
PAVM icon
2881
PAVmed
PAVM
$33.9M
$157K ﹤0.01%
142
-4
-3% -$8.7K
ALGS icon
2882
Aligos Therapeutics
ALGS
$34.9M
$156K ﹤0.01%
526
-18
-3% -$6.57K
ESPR
2883
DELISTED
Esperion Therapeutics
ESPR
$156K ﹤0.01%
31,133
-479
-2% -$3.83K
FXLV
2884
DELISTED
F45 Training Holdings Inc.
FXLV
$152K ﹤0.01%
14,001
-135
-1% -$1.69K
FBIO icon
2885
Fortress Biotech
FBIO
$88.7M
$151K ﹤0.01%
4,021
-20
-0.5% -$892
NMTR
2886
DELISTED
9 Meters Biopharma
NMTR
$148K ﹤0.01%
7,561
-163
-2% -$3.65K
ATNX
2887
DELISTED
Athenex, Inc. Common Stock
ATNX
$148K ﹤0.01%
5,457
-95
-2% -$4.01K
TAST
2888
DELISTED
Carrols Restaurant Group, Inc.
TAST
$147K ﹤0.01%
49,817
-1,692
-3% -$5.67K
VIA
2889
DELISTED
Via Renewables, Inc. Class A Common Stock
VIA
$147K ﹤0.01%
2,576
-34
-1% -$1.92K
LENZ
2890
LENZ Therapeutics
LENZ
$168M
$145K ﹤0.01%
1,669
-9
-0.5% -$746
EVLO
2891
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
$145K ﹤0.01%
1,197
+15
+1% +$2.53K
CLPT icon
2892
ClearPoint Neuro
CLPT
$433M
$144K ﹤0.01%
12,819
-334
-3% -$5K
TIG
2893
DELISTED
Trean Insurance Group, Inc. Common Stock
TIG
$143K ﹤0.01%
16,092
-267
-2% -$2.5K
RVI
2894
DELISTED
Retail Value Inc. Common Shares
RVI
$143K ﹤0.01%
45,804
-243,737
-84% -$693K
ITI
2895
DELISTED
Iteris, Inc.
ITI
$142K ﹤0.01%
35,571
-896
-2% -$4.33K
SPRY icon
2896
ARS Pharmaceuticals
SPRY
$612M
$141K ﹤0.01%
21,242
+1,229
+6% +$9.99K
IVC
2897
DELISTED
Invacare Corporation
IVC
$141K ﹤0.01%
51,731
-48,783
-49% -$180K
IBIO icon
2898
iBio
IBIO
$70M
$140K ﹤0.01%
510
-9
-2% -$3.43K
EEX
2899
DELISTED
Emerald Holding
EEX
$139K ﹤0.01%
35,094
+78
+0.2% +$327
SLDB icon
2900
Solid Biosciences
SLDB
$900M
$138K ﹤0.01%
5,260
+286
+6% +$8.74K
114 115
116
117 118

Similar funds

VAM
Vanguard Asset Management London, Ec4n 8af $117B AUM
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $113B AUM 36.92% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

RhumbLine Advisers's Q4 2021 Portfolio in Review

As of Q4 2021, RhumbLine Advisers held 3,095 positions worth $81.6B, up 10% from $73.9B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Trading was light in Q4 2021: portfolio turnover was 4.4%. RhumbLine Advisers opened 53 new positions and exited 84, leaving the 3,095-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 24% a quarter earlier, followed by Financials and Healthcare.

  • RhumbLine Advisers's largest Q4 2021 buy was Rivian: 125,331 shares worth $13M.
  • RhumbLine Advisers added most to Microsoft in Q4 2021, an estimated $65.3M increase.
  • RhumbLine Advisers's biggest Q4 2021 reduction was Berkshire Hathaway Class B, cutting an estimated $21.9M.
  • RhumbLine Advisers fully exited Kansas City Southern in Q4 2021, selling an estimated $39.1M.
  • RhumbLine Advisers's ten largest holdings make up 24% of its $81.6B portfolio in Q4 2021.
  • RhumbLine Advisers opened 53 new positions and closed 84 in Q4 2021.
  • RhumbLine Advisers's portfolio value rose 10% quarter-over-quarter to $81.6B.

Based on RhumbLine Advisers's 13F filing for Q4 2021, filed 10 Feb 2022.